AI Tokens
Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Johnson & Johnson, consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Sep 27, 2026 Jun 28, 2026 Mar 29, 2026 Dec 28, 2025 Sep 28, 2025 Jun 29, 2025 Mar 30, 2025 Dec 29, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021
Net earnings (loss) 210 5,534 5,235 5,116 5,152 5,537 10,999 3,431 2,694 4,686 3,255 4,049 26,028 5,144 (68) 3,520 4,458 4,814 5,149 4,736 3,667 6,278 6,197
Depreciation and amortization of property and intangibles 2,117 1,959 2,004 2,011 1,777 1,943 1,772 1,896 1,846 1,782 1,815 1,843 1,829 1,934 1,880 1,772 1,685 1,744 1,769 1,843 1,814 1,839 1,894
Stock based compensation 357 458 300 309 347 410 288 238 295 341 302 178 296 382 306 213 281 366 278 215 259 354 307
Asset write-downs 581 184 36 81 93 — 30 26 — 194 185 475 432 (38) 426 429 40 137 610 25 938 12 14
Charges for acquired in-process research and development assets 962 — 2 — 17 76 16 589 1,252 — — 483 — — — — — — — — — — —
Gain on Kenvue separation — — — — — — — — — — — — (20,984) — — — — — — — — — —
Net (gain) loss on sale of assets/businesses 16 (55) 12 (132) (57) 1 (75) (1) (2) (223) — — (70) (39) (8) (167) — (45) (168) (16) — (21) (580)
Deferred tax provision (1,790) (479) 159 (3,677) 2,218 825 2,172 (16) 90 (695) (1,562) (2,412) 560 (799) (1,543) 825 (139) (1,423) (926) 485 (1,879) 45 (730)
Credit losses and accounts receivable allowances 17 (4) (8) 5 (9) 7 (4) 22 (11) — — — — (1) 1 (3) (11) (9) 6 12 (8) (39) (13)
(Increase) decrease in accounts receivable 188 (1,352) (595) 391 111 (1,357) (926) 853 (96) (884) (279) 227 (252) (545) (54) 301 (205) (959) (427) (584) (252) 38 (1,604)
(Increase) decrease in inventories (150) (571) (431) (46) (748) (510) (146) (90) (299) (391) (348) 124 (706) (217) (524) (650) (620) (657) (600) (70) (360) (123) (695)
Increase (decrease) in accounts payable and accrued liabilities 2,405 2,964 (3,920) 1,266 1,997 1,240 (2,126) (1,092) 2,264 2,932 (2,483) 1,682 1,725 1,511 (2,572) 957 1,311 1,647 (2,817) 2,255 4,232 (1,714) (2,336)
(Increase) decrease in other current and non-current assets 122 950 349 1,486 (1,459) (4,877) (1,317) 768 (2,782) 532 3,199 (2,114) (222) (229) (915) (3,876) 1,036 2,532 995 (4,046) 667 (1,107) 2,522
Increase (decrease) in other current and non-current liabilities 2,685 (972) (629) 499 (270) 583 (6,509) 359 2,742 (2,641) (427) 3,328 (1,147) (2,921) 6,328 2,029 (1,552) (2,566) 110 877 (788) (248) (902)
Changes in assets and liabilities, net of effects from acquisitions and divestitures 5,250 1,019 (5,226) 3,596 (369) (4,921) (11,024) 798 1,829 (452) (338) 3,247 (602) (2,401) 2,263 (1,239) (30) (3) (2,739) (1,568) 3,499 (3,154) (3,015)
Adjustments to reconcile net earnings (loss) to cash flows from operating activities 7,510 3,082 (2,721) 2,193 4,017 (1,659) (6,825) 3,552 5,299 947 402 3,814 (18,539) (962) 3,325 1,830 1,826 767 (1,170) 996 4,623 (964) (2,123)
Net cash flows from operating activities 7,720 8,616 2,514 7,309 9,169 3,878 4,174 6,983 7,993 5,633 3,657 7,863 7,489 4,182 3,257 5,350 6,284 5,581 3,979 5,732 8,290 5,314 4,074
Additions to property, plant and equipment (1,362) (1,321) (1,049) (1,837) (1,157) (1,043) (795) (1,612) (1,029) (976) (807) (1,589) (967) (1,124) (863) (1,587) (952) (863) (607) (1,415) (747) (813) (677)
Proceeds from the disposal of assets/businesses, net (4) 63 29 312 76 53 279 52 50 363 210 121 121 76 40 221 8 66 248 45 12 51 603
Acquisitions, net of cash acquired (89) (263) — (3,082) (1) (14,458) — (1) (338) (12,996) (1,811) — — — — (17,130) 1 (271) (252) (60) — — —
Acquired in-process research and development assets/related milestones (995) — — — (16) (355) (14) (533) (1,250) — — (470) — — — — — — — — — — —
Purchases of investments (919) (155) (144) (243) (246) (180) (251) (262) (280) (554) (630) (925) (293) (5,914) (3,774) (1,221) (9,115) (13,030) (9,018) (11,551) (6,579) (6,270) (5,994)
Sales of investments 308 159 209 219 489 735 218 290 466 727 979 3,603 3,910 4,111 7,766 15,285 8,690 11,331 6,303 8,197 4,356 7,220 5,233
Credit support agreements activity, net 358 546 (31) 209 346 (2,980) 296 818 (731) (170) 1,600 (2,046) (119) (956) 158 56 (295) 239 (249) (482) 255 (310) 751
Other, including capitalized licenses and milestones (6) (139) (54) (63) (33) (36) (30) (72) (16) (81) (5) 104 (111) 31 (12) (21) (38) (111) (59) (94) (16) (297) (101)
Net cash (used for) from investing activities (2,709) (1,110) (1,040) (4,485) (542) (18,264) (297) (1,320) (3,128) (13,687) (464) (1,202) 2,541 (3,776) 3,315 (4,397) (1,701) (2,639) (3,634) (5,360) (2,719) (419) (185)
Dividends to shareholders (3,227) (3,227) (3,131) (3,131) (3,132) (3,129) (2,989) (2,984) (2,985) (2,985) (2,869) (2,865) (2,871) (3,092) (2,942) (2,954) (2,970) (2,971) (2,787) (2,791) (2,791) (2,791) (2,659)
Repurchase of common stock (1,709) (221) (4,028) (1,924) (1,902) — (2,127) (282) (539) (136) (1,475) (216) (920) (381) (3,537) (1,320) (2,165) (973) (1,577) (996) (391) (631) (1,438)
Proceeds from short-term debt, net 2,276 707 12,439 3,913 1,324 565 8,784 3,293 (1,992) 8,713 5,263 1,281 241 1,127 11,094 9,035 2,728 1,352 3,019 714 785 475 23
Repayment of short-term debt, net (6,633) (6,454) (3,223) (1,806) (5,466) (2,938) (2,120) (1,109) (4,439) (3,025) (890) (1,328) (8,034) (8,223) (5,388) (1,742) (2,607) (1,345) (856) (369) (132) (214) (475)
Proceeds from long-term debt, net of issuance costs — — — — — — 9,138 — 1 6,657 2 — — — — 1 (1) 2 — 2 2 — 1
Repayment of long-term debt (1) (1) (2,002) (2) (1,001) (3) (751) (649) (1) (802) (1) (1,049) (1) (1) (500) (1) (1) — (2,132) (350) (1) (450) (1,001)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net 743 359 1,172 1,587 1,274 107 450 124 424 95 195 187 653 265 (11) 422 87 499 321 228 265 307 236
Credit support agreements activity, net 17 60 (109) 20 25 (268) (3) 267 (276) 53 228 (281) 188 (113) (13) (1,706) 865 1,048 (235) 113 38 (82) 212
Settlement of convertible debt acquired from Shockwave — — — — — — — — — (970) — — — — — — — — — — — — —
Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to Kenvue at separation — — — — — — — — — — — — 373 — 7,674 — — — — — — — —
Proceeds from Kenvue initial public offering — — — — — — — — — — — — — 4,241 — — — — — — — — —
Cash transferred to Kenvue at separation — — — — — — — — — — — — (1,114) — — — — — — — — — —
Other 1 — (588) (26) (49) 1 40 — (75) (56) 93 (384) 168 186 (239) (35) 139 127 (138) 13 18 107 (24)
Net cash from (used for) financing activities (8,533) (8,777) 530 (1,369) (8,927) (5,665) 10,422 (1,340) (9,882) 7,544 546 (4,655) (11,317) (5,991) 6,138 1,700 (3,925) (2,261) (4,385) (3,436) (2,207) (3,279) (5,125)
Effect of exchange rate changes on cash and cash equivalents 10 5 (25) 23 (46) 154 70 (198) 119 (85) (125) 125 (168) (97) 28 119 (286) (161) 16 (53) (92) 45 (78)
Increase (decrease) in cash and cash equivalents (3,512) (1,266) 1,979 1,478 (346) (19,897) 14,369 4,125 (4,898) (595) 3,614 2,131 (1,455) (5,682) 12,738 2,772 372 520 (4,024) (3,117) 3,272 1,661 (1,314)

Based on: 10-Q (reporting date: 2026-09-27), 10-Q (reporting date: 2026-06-28), 10-Q (reporting date: 2026-03-29), 10-K (reporting date: 2025-12-28), 10-Q (reporting date: 2025-09-28), 10-Q (reporting date: 2025-06-29), 10-Q (reporting date: 2025-03-30), 10-K (reporting date: 2024-12-29), 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04).


The cash flow profile is characterized by consistently strong operating cash generation, which is periodically offset by aggressive investment in acquisitions and structured shareholder returns. While net earnings exhibit significant volatility due to non-cash adjustments and strategic divestitures, the core ability to generate cash from operations remains stable.

Operating Cash Flow Trends
Net cash flows from operating activities generally fluctuate between 3.2 billion and 9.2 billion USD per quarter. A notable increase in cash generation occurred in late 2023, coinciding with the Kenvue separation. Operating stability is supported by consistent depreciation and amortization expenses, which typically range from 1.7 billion to 2.1 billion USD. However, significant volatility is observed in net earnings, including a substantial spike to 26 billion USD in October 2023 and a dip to negative 68 million USD in April 2023, indicating that operating cash flow is a more reliable indicator of liquidity than quarterly net income.
Investing Activities and Capital Allocation
Investing activities are dominated by large, episodic outflows for acquisitions. Major expenditures are evident in December 2022 (17.1 billion USD), June 2024 (13 billion USD), and June 2025 (18.3 billion USD), reflecting a strategy of inorganic growth. Capital expenditures for property, plant, and equipment remain relatively steady, typically between 600 million and 1.8 billion USD per quarter. The organization also engages in active portfolio management, with frequent sales of investments often used to offset acquisition costs or maintain liquidity.
Financing and Shareholder Distributions
Shareholder returns are a primary use of cash, with quarterly dividend payments remaining highly consistent, gradually increasing from approximately 2.6 billion USD in early 2021 to over 3.2 billion USD by 2026. Common stock repurchases are more erratic, peaking at 4 billion USD in March 2026. Financing is managed through a combination of short-term debt issuance and repayment, with significant spikes in short-term debt proceeds observed in April 2023 and March 2026 to facilitate liquidity or funding for strategic initiatives.
Impact of Strategic Separation
The separation of Kenvue created significant anomalies in the financial data during 2023. This event is marked by a non-cash gain of 20.9 billion USD in October 2023, which necessitated a large downward adjustment to reconcile net earnings to operating cash flow. Additional impacts include the receipt of 4.2 billion USD from the initial public offering and a cash transfer of 1.1 billion USD to the separated entity.
Liquidity and Net Cash Position
The net change in cash and cash equivalents shows extreme variance, driven by the timing of large-scale acquisitions and debt movements. The most significant fluctuations occurred in early 2025, with a cash increase of 14.4 billion USD in March followed by a decrease of nearly 20 billion USD in June. Despite these swings, the sustained operating cash flow provides the necessary foundation to support both strategic investments and consistent dividend obligations.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?